| Eleanore R Hobbs, MD | |
|
126 6th Ave. Sw, St. Luke Community Clinci Ronan, Ronan, MT 59864 | |
| (406) 676-4441 | |
| (406) 676-0835 |
| Full Name | Eleanore R Hobbs |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 30 Years |
| Location | 126 6th Ave. Sw, Ronan, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740341189 | NPI | - | NPPES |
| 0035321 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 8731 (Montana) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 214892-1 (New York) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Community Hospital | 5496659567 | 58 |
News Archive
These growths may have important clinical implications in the management of patients, enabling early discontinuation of potentially toxic chemotherapy drugs.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
GHX today announced the market segment winners of the seventh annual Best-in-Class Awards, recognizing medical-surgical manufacturers that achieved the top-share position in six specific markets: Hospital, Long-Term Care, Treatment Centers, Home Health Care, Physician Office and Clinical Laboratory, which is a new category this year.
Shortening end caps on chromosomes in human cervical cancer cells disrupts DNA repair signaling, increases the cells' sensitivity to radiation treatment and kills them more quickly, according to a study in Cancer Prevention Research.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
› Verified 1 days ago
| Entity Name | St Lukes Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306911169 PECOS PAC ID: 5496659567 Enrollment ID: O20031121000276 |
News Archive
These growths may have important clinical implications in the management of patients, enabling early discontinuation of potentially toxic chemotherapy drugs.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
GHX today announced the market segment winners of the seventh annual Best-in-Class Awards, recognizing medical-surgical manufacturers that achieved the top-share position in six specific markets: Hospital, Long-Term Care, Treatment Centers, Home Health Care, Physician Office and Clinical Laboratory, which is a new category this year.
Shortening end caps on chromosomes in human cervical cancer cells disrupts DNA repair signaling, increases the cells' sensitivity to radiation treatment and kills them more quickly, according to a study in Cancer Prevention Research.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eleanore R Hobbs, MD 126 6th Ave Sw, Ronan, MT 59864-2600 Ph: (406) 676-4441 | Eleanore R Hobbs, MD 126 6th Ave. Sw, St. Luke Community Clinci Ronan, Ronan, MT 59864 Ph: (406) 676-4441 |
News Archive
These growths may have important clinical implications in the management of patients, enabling early discontinuation of potentially toxic chemotherapy drugs.
Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.
GHX today announced the market segment winners of the seventh annual Best-in-Class Awards, recognizing medical-surgical manufacturers that achieved the top-share position in six specific markets: Hospital, Long-Term Care, Treatment Centers, Home Health Care, Physician Office and Clinical Laboratory, which is a new category this year.
Shortening end caps on chromosomes in human cervical cancer cells disrupts DNA repair signaling, increases the cells' sensitivity to radiation treatment and kills them more quickly, according to a study in Cancer Prevention Research.
Violence and conflict in areas affected by war, such as Gaza, can have a devastating effect on the mental health of the children exposed to it, according to research at the University of Leicester.
› Verified 1 days ago